Medical Xpress

Bariatric surgery-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure: Study

Bariatric surgery has emerged as an effective means of reducing weight in morbidly obese individuals, while also significantly improving diabetes. Currently, laparoscopic sleeve gastrectomy (LSG) and ...
News Medical

ApoA-IV surge after bariatric surgery enhances insulin secretion and energy expenditure

Bariatric surgery has emerged as an effective means of reducing weight in morbidly obese individuals, while also significantly improving diabetes. Currently, laparoscopic sleeve gastrectomy (LSG) and ...
Monthly Prescribing Reference

FDA Approves Myxredlin, a Ready-to-Use Insulin for IV Infusion

The FDA has approved Myxredlin (Baxter), the first ready-to-use insulin for intravenous (IV) infusion for use in acute care settings under medical supervision. The Food and Drug Administration (FDA) ...
Nasdaq

Baxter Announces U.S. FDA Approval of Myxredlin, The First and Only Ready-To-Use Insulin for IV Infusion

Offers extended shelf life of 30 days at room temperature or 24 months refrigerated Novel, ready-to-use presentation eliminates need for admixing and batching Available in standardized concentration ...
The American Journal of Managed Care

Subcutaneous Insulin Linked to Reduced Hospital Costs, LOS in Children With Mild DKA

Treating children with mild diabetic ketoacidosis (DKA) using subcutaneous (SC) insulin aspart was linked to lower hospital costs and better efficacy of DKA management, compared with using intravenous ...